These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Efficacy of caffeic acid phenethyl ester (CAPE) in skin B16-F0 melanoma tumor bearing C57BL/6 mice. Kudugunti SK; Vad NM; Ekogbo E; Moridani MY Invest New Drugs; 2011 Feb; 29(1):52-62. PubMed ID: 19844662 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of acetylsalicylic acid (aspirin) in skin B16-F0 melanoma tumor-bearing C57BL/6 mice. Vad NM; Kudugunti SK; Wang H; Bhat GJ; Moridani MY Tumour Biol; 2014 May; 35(5):4967-76. PubMed ID: 24492939 [TBL] [Abstract][Full Text] [Related]
8. Biochemical basis of 4-hydroxyanisole induced cell toxicity towards B16-F0 melanoma cells. Moridani MY Cancer Lett; 2006 Nov; 243(2):235-45. PubMed ID: 16427188 [TBL] [Abstract][Full Text] [Related]
9. Gene silencing of indoleamine 2,3-dioxygenase 2 in melanoma cells induces apoptosis through the suppression of NAD+ and inhibits in vivo tumor growth. Liu Y; Zhang Y; Zheng X; Zhang X; Wang H; Li Q; Yuan K; Zhou N; Yu Y; Song N; Fu J; Min W Oncotarget; 2016 May; 7(22):32329-40. PubMed ID: 27058624 [TBL] [Abstract][Full Text] [Related]
10. Relationship between 4-hydroxyanisole toxicity and dopa oxidase activity for three melanoma cell lines. Rodriguez-Vicente J; Vicente-Ortega V; Canteras-Jordana M; Calderon-Rubiales F Melanoma Res; 1997 Oct; 7(5):373-81. PubMed ID: 9429220 [TBL] [Abstract][Full Text] [Related]
11. Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol. Inoue S; Hasegawa K; Ito S; Ozeki H; Solano F; Jiménez-Cervantes C; Wakamatsu K; Fujita K Cancer Res; 1995 Jun; 55(12):2603-7. PubMed ID: 7780975 [TBL] [Abstract][Full Text] [Related]
12. Metabolic bioactivation and toxicity of ethyl 4-hydroxybenzoate in human SK-MEL-28 melanoma cells. Vad NM; Shaik IH; Mehvar R; Moridani MY J Pharm Sci; 2008 May; 97(5):1934-45. PubMed ID: 17847068 [TBL] [Abstract][Full Text] [Related]
13. Astaxanthin pretreatment attenuates acetaminophen-induced liver injury in mice. Zhang J; Zhang S; Bi J; Gu J; Deng Y; Liu C Int Immunopharmacol; 2017 Apr; 45():26-33. PubMed ID: 28152447 [TBL] [Abstract][Full Text] [Related]
14. Acetaminophen toxicity in rat and mouse hepatocytes in vitro. Kučera O; Endlicher R; Rychtrmoc D; Lotková H; Sobotka O; Červinková Z Drug Chem Toxicol; 2017 Oct; 40(4):448-456. PubMed ID: 27960556 [TBL] [Abstract][Full Text] [Related]
15. Nicotinamide inhibits melanoma in vitro and in vivo. Scatozza F; Moschella F; D'Arcangelo D; Rossi S; Tabolacci C; Giampietri C; Proietti E; Facchiano F; Facchiano A J Exp Clin Cancer Res; 2020 Oct; 39(1):211. PubMed ID: 33028392 [TBL] [Abstract][Full Text] [Related]
16. Tyrosinase-activated prodrug nanomedicine as oxidative stress amplifier for melanoma-specific treatment. Pu Y; Zhou B; Xiang H; Wu W; Yin H; Yue W; Yin Y; Li H; Chen Y; Xu H Biomaterials; 2020 Nov; 259():120329. PubMed ID: 32836058 [TBL] [Abstract][Full Text] [Related]
17. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Zaher H; Buters JT; Ward JM; Bruno MK; Lucas AM; Stern ST; Cohen SD; Gonzalez FJ Toxicol Appl Pharmacol; 1998 Sep; 152(1):193-9. PubMed ID: 9772215 [TBL] [Abstract][Full Text] [Related]
18. Tyrosinase expression and melanogenesis in melanotic and amelanotic B16 mouse melanoma cells. Burchill SA; Bennett DC; Holmes A; Thody AJ Pathobiology; 1991; 59(5):335-9. PubMed ID: 1910528 [TBL] [Abstract][Full Text] [Related]
19. Antimelanoma activity of perphenazine and prochlorperazine in human COLO829 and C32 cell lines. Otręba M; Pajor M; Warncke JD Naunyn Schmiedebergs Arch Pharmacol; 2019 Oct; 392(10):1257-1264. PubMed ID: 31172223 [TBL] [Abstract][Full Text] [Related]
20. Acetaminophen-induced depletion of glutathione and cysteine in the aging mouse kidney. Richie JP; Lang CA; Chen TS Biochem Pharmacol; 1992 Jul; 44(1):129-35. PubMed ID: 1632827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]